Related content

Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab

By Pickartz T.   Ringel F.   Wedde M.   Renz H.   Klein A.   von Neuhoff N.   Dreger P.   Kreuzer K.A.   Schmidt C.A.   Srock S.   Schoeler D.   Schriever F.  

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1410-1416

Elsevier

Access to resources Recommend Favorite

Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin’s disease

By Kömürcü Ş.   Özet A.   Altundag M.   Arpaci F.   Öztürk B.   Celasun B.   Tezcan Y.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 57-58

Springer Publishing Company

Access to resources Recommend Favorite

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

By Kim Min   Kim Shin   Lee Sung   Sym Sun   Lee Dae   Jang Seongsoo   Park Chan   Chi Hyun   Huh Jooryung   Suh Cheolwon  

Annals of Hematology, Vol. 86, Iss. 6, 2007-06 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody

By Mourad Yasser   Taher Ali   Chehal Aref   Shamseddine Ali  

Annals of Hematology, Vol. 83, Iss. 5, 2004-05 ,pp. : 319-321

Springer Publishing Company

Access to resources Recommend Favorite

Prophylactic use of granulocyte colony-stimulating factor after consolidation therapy with high-dose cytarabine for acute myeloid leukemia

By Shadman Mazyar   Estey Elihu H  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 131-133

Informa Healthcare

Access to resources Recommend Favorite